Most Nursing Home Residents with Advanced Dementia Get Medications With Questionable Benefits and Substantial Costs
According to a new AHRQ-funded study, more than half of nursing home residents with advanced dementia – a terminal illness marked by severe cognitive impairment and functional dependence – continue to receive medications that may not help them, but incur substantial financial cost. The study and abstract, “Use of Medications of Questionable Benefit in Advanced Dementia,” were published in the November 2014 issue ofJAMA Internal Medicine. An analysis of more than 5,400 residents at 460 facilities (using 2009-2010 data) found that nearly 54 percent of residents received at least one medication of questionable benefit. The average 90-day expenditure for medications with questionable benefits was $816. This accounts for 35.2 percent of the total average 90-day medication costs for residents with advanced dementia who were prescribed common medications with questionable benefits.
JAMA Intern Med. 2014 Nov 1;174(11):1763-71. doi: 10.1001/jamainternmed.2014.4103.
Use of medications of questionable benefit in advanced dementia.
DESIGN, SETTING, AND PARTICIPANTS:
MAIN OUTCOMES AND MEASURES:
CONCLUSIONS AND RELEVANCE:
- [PubMed - in process]